Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Caseinolytic protease P subunit 2 (ClpP2) is a component of the bacterial Clp protease complex, a major ATP-dependent serine protease that ensures protein quality control, stress tolerance, and turnover of regulatory proteins[1][2][3][7]. Structurally, ClpP2 forms part of a barrel-like tetradecamer (14 subunits, often in conjunction with ClpP1) that degrades misfolded, damaged, or regulatory proteins that are translocated into its proteolytic chamber by AAA+ ATPase chaperones such as ClpX or ClpC[1][5][7]. In several pathogenic bacteria (e.g., Mycobacterium tuberculosis, Listeria monocytogenes, Leptospira interrogans, Chlamydia trachomatis), ClpP2 is indispensable for growth, virulence, and adaptation to stress[3][4][6][7]. ClpP2 has emerged as a promising antibiotic target: chemical activators (including ADEPs and certain peptidomimetic boronates) dysregulate the protease, leading to lethal degradation of essential bacterial proteins, while inhibitors can block its proteolytic function[5][3].
Small-molecule activators (such as ADEPs or Bz-LL) dysregulate or hyperactivate ClpP2, resulting in uncontrolled proteolysis and bacterial death; inhibitors bind active sites to block proteolysis
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caseinolytic protease P subunit 2 (ClpP2).